Oseltamivir phosphate is an antiviral medication used for the treatment and prevention of influenza A and B viruses [1]. It is marketed under the brand name Tamiflu [2].
How does oseltamivir phosphate work?
Oseltamivir phosphate is a neuraminidase inhibitor [1]. It works by blocking the action of an enzyme called neuraminidase, which is found on the surface of the influenza virus. This enzyme is essential for the virus to spread from infected cells to healthy cells. By inhibiting neuraminidase, oseltamivir phosphate prevents the release of new virus particles, thereby limiting the spread of infection [1].
When is oseltamivir phosphate prescribed?
Oseltamivir phosphate is typically prescribed for individuals with symptoms of the flu, such as fever, cough, sore throat, body aches, headache, chills, and fatigue [3]. It is most effective when started within 48 hours of the onset of flu symptoms [1]. The medication can also be used as a preventive measure for individuals who have been exposed to the influenza virus, such as during an outbreak or after close contact with an infected person [3].
What are the potential side effects of oseltamivir phosphate?
Common side effects associated with oseltamivir phosphate include nausea, vomiting, headache, and stomach pain [4]. Less common but more serious side effects can include allergic reactions, skin reactions, and neurological or behavioral changes, particularly in children and adolescents [4]. It is important to consult a healthcare professional if any concerning side effects arise.
When does the patent for Tamiflu expire?
The original patent for oseltamivir phosphate, the active ingredient in Tamiflu, was filed in 1996 and expired in 2017 in the United States [5]. However, secondary patents related to specific formulations, manufacturing processes, or methods of use may exist [5]. Information on patent expiry dates for specific pharmaceutical products can be found on resources like DrugPatentWatch.com [5].
Are there generic versions of oseltamivir phosphate available?
Following the expiry of primary patents, generic versions of oseltamivir phosphate have become available. These generic medications offer a more affordable alternative to the branded Tamiflu [6].
How does oseltamivir phosphate compare to other flu treatments?
Oseltamivir phosphate is one of several antiviral medications approved for treating influenza. Other neuraminidase inhibitors include zanamivir (Relenza) and peramivir (Rapivab). Baloxavir marboxil (Xofluza) is a different class of antiviral that inhibits cap-dependent endonuclease. The choice of treatment often depends on factors such as the patient's age, underlying health conditions, the specific strain of influenza, and resistance patterns [7].
Sources:
[1] https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/oseltamivir-phosphate-tamiflu-information
[2] https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021207s016,021794s005,021900s013lbl.pdf
[3] https://www.mayoclinic.org/drugs-supplements/oseltamivir-oral-route/proper-use/drg-20068561
[4] https://www.webmd.com/drugs/2/20494/oseltamivir-oral/details
[5] https://drugpatentwatch.com/
[6] https://www.goodrx.com/oseltamivir
[7] https://www.cdc.gov/flu/treatment/what-to-do-if-you-get-sick.htm